120 related articles for article (PubMed ID: 2372903)
1. Heparin-resistant thrombus formation by endovascular stents in baboons. Interruption by a synthetic antithrombin.
Krpski WC; Bass A; Kelly AB; Marzec UM; Hanson SR; Harker LA
Circulation; 1990 Aug; 82(2):570-7. PubMed ID: 2372903
[TBL] [Abstract][Full Text] [Related]
2. Lasting safe interruption of endarterectomy thrombosis by transiently infused antithrombin peptide D-Phe-Pro-ArgCH2Cl in baboons.
Lumsden AB; Kelly AB; Schneider PA; Krupski WC; Dodson T; Hanson SR; Harker LA
Blood; 1993 Apr; 81(7):1762-70. PubMed ID: 8461462
[TBL] [Abstract][Full Text] [Related]
3. Interruption of acute platelet-dependent thrombosis by the synthetic antithrombin D-phenylalanyl-L-prolyl-L-arginyl chloromethyl ketone.
Hanson SR; Harker LA
Proc Natl Acad Sci U S A; 1988 May; 85(9):3184-8. PubMed ID: 3362867
[TBL] [Abstract][Full Text] [Related]
4. Prevention of heparin-resistant thrombotic occlusion of hollow-fiber hemodialyzers by synthetic antithrombin.
Kelly AB; Hanson SR; Henderson LW; Harker LA
J Lab Clin Med; 1989 Oct; 114(4):411-8. PubMed ID: 2794754
[TBL] [Abstract][Full Text] [Related]
5. Small-caliber heparin-coated ePTFE grafts reduce platelet deposition and neointimal hyperplasia in a baboon model.
Lin PH; Chen C; Bush RL; Yao Q; Lumsden AB; Hanson SR
J Vasc Surg; 2004 Jun; 39(6):1322-8. PubMed ID: 15192575
[TBL] [Abstract][Full Text] [Related]
6. Reduction in thrombus formation by placement of endovascular stents at endarterectomy sites in baboon carotid arteries.
Krupski WC; Bass A; Kelly AB; Hanson SR; Harker LA
Circulation; 1991 Oct; 84(4):1749-57. PubMed ID: 1914112
[TBL] [Abstract][Full Text] [Related]
7. Reduced thrombus formation by hyaluronic acid coating of endovascular devices.
Verheye S; Markou CP; Salame MY; Wan B; King SB; Robinson KA; Chronos NA; Hanson SR
Arterioscler Thromb Vasc Biol; 2000 Apr; 20(4):1168-72. PubMed ID: 10764689
[TBL] [Abstract][Full Text] [Related]
8. Local delivery of a synthetic antithrombin with a hydrogel-coated angioplasty balloon catheter inhibits platelet-dependent thrombosis.
Nunes GL; Hanson SR; King SB; Sahatjian RA; Scott NA
J Am Coll Cardiol; 1994 Jun; 23(7):1578-83. PubMed ID: 8195517
[TBL] [Abstract][Full Text] [Related]
9. Interruption of vascular thrombus formation and vascular lesion formation by dietary n-3 fatty acids in fish oil in nonhuman primates.
Harker LA; Kelly AB; Hanson SR; Krupski W; Bass A; Osterud B; FitzGerald GA; Goodnight SH; Connor WE
Circulation; 1993 Mar; 87(3):1017-29. PubMed ID: 8443878
[TBL] [Abstract][Full Text] [Related]
10. Factors influencing acute thrombus formation on carotid artery vascular grafts.
Torem S; Schneider PA; Paxton LD; Yasuda H; Hanson SR
ASAIO Trans; 1988; 34(4):916-20. PubMed ID: 3219254
[TBL] [Abstract][Full Text] [Related]
11. Thromboembolic potential of synthetic vascular grafts in baboons.
Schneider PA; Kotzé HF; Heyns AD; Hanson SR
J Vasc Surg; 1989 Jul; 10(1):75-82. PubMed ID: 2526235
[TBL] [Abstract][Full Text] [Related]
12. Silyl-heparin bonding improves the patency and in vivo thromboresistance of carbon-coated polytetrafluoroethylene vascular grafts.
Laredo J; Xue L; Husak VA; Ellinger J; Singh G; Zamora PO; Greisler HP
J Vasc Surg; 2004 May; 39(5):1059-65. PubMed ID: 15111862
[TBL] [Abstract][Full Text] [Related]
13. Antithrombin nanoparticles inhibit stent thrombosis in ex vivo static and flow models.
Palekar RU; Vemuri C; Marsh JN; Arif B; Wickline SA
J Vasc Surg; 2016 Nov; 64(5):1459-1467. PubMed ID: 26482989
[TBL] [Abstract][Full Text] [Related]
14. Antihemostatic and antithrombotic effects of monoclonal antibodies against von Willebrand factor in nonhuman primates.
Krupski WC; Bass A; Cadroy Y; Kelly AB; Harker LA; Hanson SR
Surgery; 1992 Aug; 112(2):433-9; discussion 439-40. PubMed ID: 1641780
[TBL] [Abstract][Full Text] [Related]
15. Discrimination between platelet-mediated and coagulation-mediated mechanisms in a model of complex thrombus formation in vivo.
Cadroy Y; Horbett TA; Hanson SR
J Lab Clin Med; 1989 Apr; 113(4):436-48. PubMed ID: 2522978
[TBL] [Abstract][Full Text] [Related]
16. Roles of thrombin and platelet membrane glycoprotein IIb/IIIa in platelet-subendothelial deposition after angioplasty in an ex vivo whole artery model.
Kaplan AV; Leung LL; Leung WH; Grant GW; McDougall IR; Fischell TA
Circulation; 1991 Sep; 84(3):1279-88. PubMed ID: 1832095
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of platelet deposition and neointimal hyperplasia of heparin-coated small-caliber ePTFE grafts in a canine femoral artery bypass model.
Lin PH; Bush RL; Yao Q; Lumsden AB; Chen C
J Surg Res; 2004 May; 118(1):45-52. PubMed ID: 15093716
[TBL] [Abstract][Full Text] [Related]
18. Interruption of vascular thrombosis by bolus anti-platelet glycoprotein IIb/IIIa monoclonal antibodies in baboons.
Krupski WC; Bass A; Kelly AB; Ruggeri ZM; Harker LA; Hanson SR
J Vasc Surg; 1993 Feb; 17(2):294-303; discussion 303-4. PubMed ID: 8433425
[TBL] [Abstract][Full Text] [Related]
19. Heparin immobilization reduces thrombogenicity of small-caliber expanded polytetrafluoroethylene grafts.
Heyligers JM; Verhagen HJ; Rotmans JI; Weeterings C; de Groot PG; Moll FL; Lisman T
J Vasc Surg; 2006 Mar; 43(3):587-91. PubMed ID: 16520178
[TBL] [Abstract][Full Text] [Related]
20. Preformed confluent endothelial cell monolayers prevent early platelet deposition on vascular prostheses in baboons.
Schneider PA; Hanson SR; Price TM; Harker LA
J Vasc Surg; 1988 Sep; 8(3):229-35. PubMed ID: 3138436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
